References
- IeiriITakaneHHirotaTOtsuboKHiguchiSGenetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapyExpert Opin Drug Metab Toxicol200625 651 67417014387
- FukasawaTSuzukiAOtaniKEffects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepinesJ Clin Pharm Ther2007324 333 34117635335
- WeiCYLeeMTChenYTPharmacogenomics of adverse drug reactions: implementing personalized medicineHum Mol Genet201221R1 R58 R6522907657
- KimCOOhESKimHParkMSPharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?Drug Des Devel Ther201711 503 512
- no authors listedMass Spectrometry in Bioanalysis. Particle Sciences – Technical Brief20094 1 2 Available from: http://www.particlesciences.com/news/technical-briefs/2009/mass-spectrometry-bioanalysis.htmlAccessed March 14, 2017
- PucciVDi PalmaSAlfieriABonelliFMonteagudoEA novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPEJ Pharm Biomed Anal2009505 867 87119553055